Ledger.Open graph →
SEC Form D · filed April 13, 2018

EIP Pharma, Inc

Offering
$20.5M
Sold
$20.5M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Tatjana May · Cambridge, MADirectorSylvie Gregoire · Cambridge, MAExec · DirectorJohn Alam · Cambridge, MAExec · DirectorGangesh Ganesan · San Jose, CAExec · DirectorS. Atiq Raza · San Jose, CAExec · DirectorJoshua D. Welch · Houston, TXDirectorMorgan Good · Vancouver, British Columbia, CanadaDirectorBocking Leighton · Vancouver, British Columbia, CanadaExec · DirectorChristopher Fiumara · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗